Activity aim
This clinical audit will guide GPs through the process of identifying patients for whom herpes zoster (HZ) vaccination is recommended, and outlines the evidence and updated Australian recommendations for administering the HZ vaccine.
Now fully updated in line with updates to the Australian Immunisation Handbook including recent changes in eligibility for zoster vaccination under the National Immunisation Program (NIP), and the removal of Zostavax
Why take part in this program?
- Access a comprehensive pre-learning activity presented by Associate Professor John Litt AM
- Evaluate evidence-based recommendations for HZ vaccination in patients 50 years or older.
- Earn 6 CPD hours upon completion.
Inclusion criteria
Patients who are eligible for this clinical audit are adults who are:
- Aged 50 years or over
- Have not previously received the recombinant herpes zoster vaccine (Shingrix)
How long should it take?
The program has been designed to take approximately 6-8 weeks to complete. This includes patient recall from your practice, patient consult and program evaluation.
Tips to recruit patients
Recruitment may occur:
- Opportunistically as you review appropriate patients as part of usual care.
- By active recall.
Learning outcomes
Register for this revised audit for measuring outcomes hours for 2026.
Presenter
A/Prof John Litt AM is a General Practitioner; Public health physician and has been the Associate Professor in the Discipline of General Practice at Flinders University.
His teaching activities focussed on coordinating the teaching of general practice and arranging placement for medical students in the Flinders University Medical Course. His major clinical and research interests are in prevention and its implementation He has over 100 refereed publications (journal articles, book and book chapters) including co authorship of the Australian General Practice Smoking Cessation Guidelines and its updates and the RACGP prevention guidelines.
Related content
